Factors of severity at admission during an epidemic of dengue 1 in New Caledonia (South Pacific) in 2003

Scandinavian Journal of Infectious Diseases

Volumn 38, Issue 8, 2006, Pages 675-681

  Bouldouyre, M A ^a   Baumann, F ^a   Berlioz Arthaud, A ^a   Chungue, E ^a   Lacassin, F ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMYLASE; BILIRUBIN; CREATINE; IMMUNOGLOBULIN M;

ADOLESCENT; ADULT; AGED; ARTICLE; BLEEDING; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA ANALYSIS SOFTWARE; DENGUE; DISEASE SEVERITY; EPIDEMIC; FEMALE; FREQUENCY ANALYSIS; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; HUMAN CELL; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUROLOGIC DISEASE; NEW CALEDONIA; PATIENT TRANSPORT; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; RISK ASSESSMENT; SHOCK; STATISTICAL SIGNIFICANCE; THROMBOCYTE COUNT; UNIVARIATE ANALYSIS;

AMYLASES; BILIRUBIN; BLOOD PLATELETS; CREATININE; DENGUE; DENGUE VIRUS; FEMALE; HUMANS; IMMUNOGLOBULIN M; INTENSIVE CARE; MALE; MIDDLE AGED; NEW CALEDONIA; PROGNOSIS; RETROSPECTIVE STUDIES; TRIAGE;

EID: 33746616419     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.1080/00365540600606432     Document Type: Article

References (20)

1. Gibbons, RV and Vaughn, DW. (2002) Dengue: An escalating problem Br Med J, 324, pp. 1563-6.
2. World Health Organisation. Dengue and dengue haemorrhagic fever. Fact sheet No. 117, Revised April 2002. http://www.who.int/inf-fs/fr/ am117.htlm
3. Mairuhu, ATA and Wagenaar, J and Brandjes, DPM and van Gorp, ECM. (2004) Dengue: An arthropod-borne disease of global importance Eur J Clin Microbiol Infect Dis, 23, pp. 425-33.
4. World Health Organisation (1997). Dengue haemorrhagic fever: Diagnosis, treatment, prevention and control. 2nd edn. WHO, Geneva.
5. Wilder-Smith, A and Schwartz, E. (2005) Dengue in travellers NEJM, 353, pp. 924-32.
6. Murgue, B and Deparis, X and Chungue, E and Cassar, O and Roche, C. (1999) Dengue: An evaluation of dengue severity in French Polynesia based on an analysis of 403 laboratory-confirmed cases Tropical Medicine and International Health, 11, pp. 765-73.
7. Lanciotti, RS and Calisher, CH and Gubler, DJ and Chang, G-J and Vordam, AV. (1992) Rapid detection and typing of dengue viruses from clinical samples using reverse transcriptase chain reaction J Clin Microbiol, 30, pp. 545-55.
8. Wills, BA and Dung, NM and Loan, HT and Tam, DTH and Thuy, TTN and Minh, LTT and (2005) Comparison of 3 fluid solutions for resuscitation in dengue shock syndrome NEJM, 353, pp. 877-89.
9. Wichman, O and Hongsiriwon, S and Bowonwatanuwong, C and Chotivanich, K and Sukthana and Pukrittayakamee, S. (2004) Risk factors and clinical features associated with severe dengue infection in adults and children during the 2001 epidemic in Chonburi, Thailand Tropical Medicine and International Health, 9, pp. 1022-9.
10. Kliks, SC and Nimmanitya, S and Nisalak, A and Burke, DS. (1988) Evidence that maternal dengue antibodies are important in the development of dengue haemorraghic fever in infants Am J Trop Med Hyg, 38, pp. 411-9.
11. Guzman, MG and Kouri, GP and Bravo, J and Soler, M and Vasquez, S and Morier, L. (1990) Dengue haemorrhagic fever in Cuba. A retrospective sero-epidemiological study Am J Trop Med Hyg, 42, pp. 179-84.
12. Wahid, SF and Sanusi, S and Zawawi, MM and Ali, RA. (2000) A comparison of the pattern of liver involvement in dengue haemorrhagic fever with classic dengue fever Southeast Asian J Trop Med Public Health, 31, pp. 259-63.
13. Pancharoen, C and Rungsarannont, A and Thisyakorn, U. (2002) Hepatic dysfunction in dengue patients with varying severity J Med Assoc Thai, 85(Suppl. 1), pp. 298-301.
14. van Gorp, ECM and Suharti, C and Mairuhu, ATA and Dolmans, WMV and van der Ven, J and Demacker, PNM and van der Mer, JWM. (2002) Changes in the plasma lipid profile as a potential predictor of clinical outcome in dengue haemorraghic fever CID, 34, pp. 1150-3.
15. Vaughn, DW and Green, S and Kalayanarooj, S and Innis, BL and Nimmannitya, S and Suntayakorn, S and (2000) Dengue viraemia titre, antibody response pattern, and virus serotype correlate with disease severity JID, 181, pp. 2-9.
16. Murgue, B and Roche, C and Chungue, E and Deparis, X. (2000) Prospective study of the duration and magnitude of viraemia children hospitalized during the 1996-1997 dengue 2 outbreak in French Polynesia J Med Virol, 60, pp. 432-8.
17. Libraty, DH and Young, PR and Pickering, D and Endy, TP and Kalayanarooj, S and Green, S and (2002) High circulating levels of the dengue virus non-structural protein NS1 early in dengue haemorrhagic fever JID, 186, pp. 1165-8.
18. Alcon, S and Talarmin, A and Debruyne, M and Falconar, A and Deubel, V and Flamand, M. (2002) Enzyme-linked immunosorbent assay specific to dengue virus type 1 non-structural NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections J Clin Microbiol, 40, pp. 376-81.
19. Murgue, B and Cassar, O and Deparis, X. (2001) Plasma concentrations of sVCAM-1 and severity of dengue infections J Med Virol, 65, pp. 97-104.
20. Koraka, P and Murgue, B and Deparis, X and van Gorp, EC and Setiati, TE and Osterhaut Groen, J. (2004) Elevation of soluble VCAM-1 plasma levels in children with a dengue virus infection of varying severity J Med Virol, 72, pp. 445-50.